Aida Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AIDA research report →
About the company
Aida Pharmaceuticals, Inc. , together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing.
- CEO
- Biao Jin
- IPO
- 2005
- Employees
- 450
- HQ
- Hangzhou, CN
Price Chart
- Market Cap
- $8.10K
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 3.41
- Div Yield
- 0.00%
- Gross Margin
- 50.31%
- Op Margin
- 18.64%
- Net Margin
- 9.38%
- ROE
- 23.15%
- ROIC
- 8.05%
- Revenue
- $29.20M · -1.48%
- Net Income
- $2.74M · 88.45%
- EPS
- $0.10 · 66.67%
- Op Income
- $5.45M
- FCF YoY
- 1652.60%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 17.62
- Avg Volume
- 1.20K
Get TickerSpark's AI analysis on AIDA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AIDA coverage
Recent articles, reports, and earnings notes.
No research on AIDA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AIDA report →Similar companies
Peers in the same neighborhood.